CalciMedica
CALC • NASDAQ
CalciMedica is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO A. Rachel Leheny, with a market cap of $9.0M.
CEOA. Rachel Leheny
Next Earnings
Upcoming earnings announcement for CalciMedica
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.28
Earnings History
Past 12 earnings reports for CalciMedica
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | FY 2025 | -$1.97Est: -$1.76 | -11.9% | - | — |  10-K |
| Mar 3, 2026 | Q4 2025 | -$0.69Est: -$0.47 | -46.8% | - | — | 10-K |
| Nov 12, 2025 | Q3 2025 | -$0.52Est: -$0.41 | -26.8% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.40Est: -$0.40 | 0.0% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.36Est: -$0.50 | +28.0% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.34Est: -$0.48 | +29.2% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.50Est: -$0.50 | 0.0% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.36Est: -$0.52 | +30.8% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | $0.01Est: -$0.74 | +101.4% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.23 | — | - | — | 10-K/A |
| Nov 9, 2023 | Q3 2023 | -$0.82 | — | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$1.11Est: -$1.04 | -6.7% | - | — | — |